Investor Overview At Gilead we are inspired by the opportunity to address unmet medical needs for patients living with life-threatening diseases around the world. Stock Quote Stock Quote Volume: Oct 28, 2020 10:23 AM EDT Latest News October 23, 2020 Gilead Sciences Completes Acquisition of Immunomedics, Inc. October 22, 2020 U.S. Food and Drug Administration Approves Gilead’s Antiviral Veklury® (remdesivir) for Treatment of COVID-19 October 22, 2020 Anthony Welters Joins Gilead Sciences’ Board of Directors View All Events Oct 28, 2020 at 4:30 PM EDT Third Quarter 2020 Gilead Sciences Earnings Conference Call Sep 13, 2020 at 5:00 PM EDT Gilead Sciences Conference Call Jul 30, 2020 at 4:30 PM EDT Second Quarter 2020 Gilead Sciences Earnings Conference Call View All
